शुभ दीपावलीDiwali offer: 3 months free on yearly plans · ends 11 NovSee plans
LXCHEMNSELaxmi Organic Industries Limited· Chemicals & PetrochemicalsHighNeutral
Announced Thu, 5 Feb, 2026 · 12:44 IST

Q3 FY26 Results: Revenue Down 8% YoY, PAT Falls 29% to Rs 198 mn

Revenue DeclineResults RestatedResults View source PDFExplain this filing

LXCHEM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-1.3%Reaction day
₹147.70
prior close
₹144.86
announcement price
In-mkt
timing
Nifty Microcap 250market · index membership as recorded later (tracked since Jun 2026)-1.0%-0.3% vs market
Specialty Chemicals peers, median of 88sector-0.6%-0.6% vs sector

On the reaction day the stock moved 0.3 pts less than Nifty Microcap 250 and 0.6 pts less than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+0.1
10m
+0.2
15m
-0.1
30m
+0.3
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-1.3-1.0-0.3-0.6-0.6
Next day
-3.2-1.8-1.4-0.8-2.4
2d
+3.3+0.8+2.6+1.2+2.1
3d
+3.5+1.8+1.8+1.3+2.2
4d
+2.0+1.2+0.7+2.0+0.0
5d
+3.2+0.7+2.4+0.4+2.8
1w
-4.7-1.5-3.3-1.7-3.0
15d
-11.3-2.5-8.9-4.2-7.2
1m
-21.0-7.2-13.8-6.9-14.1
2m
-19.1-8.9-10.2-8.8-10.2
3m
-1.5+5.5-7.0+4.6-6.1
UpDownMarket · Nifty Microcap 250Sector · Specialty Chemicals peers, median of 88Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Q3 FY26 standalone revenue at Rs 7,069 mn, down 8% YoY from Rs 7,679 mn. Q3 PAT fell 29% to Rs 198 mn from Rs 278 mn. For 9M, revenue Rs 20,852 mn vs Rs 22,303 mn and PAT Rs 567 mn vs Rs 895 mn. Results include one-off gains of Rs 407 mn electricity liability reversal and Rs 234 mn GST incentive. Depreciation method changed to straight line. Comparatives restated for YFCPL amalgamation. Board re-appointed Dr Rajiv Banavali as Independent Director for 2 years.

Likely market impact

Revenue and earnings declined YoY despite one-off gains boosting reported numbers. Underlying demand weak. Comparatives restated for YFCPL merger.